RETINOPATHY OF PREMATURITY
Clinical trials for RETINOPATHY OF PREMATURITY explained in plain language.
Never miss a new study
Get alerted when new RETINOPATHY OF PREMATURITY trials appear
Sign up with your email to follow new studies for RETINOPATHY OF PREMATURITY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New study monitors eylea in premature Babies' eye disease
Disease control OngoingThis study follows 75 Japanese babies with retinopathy of prematurity (ROP) who are being treated with Eylea, a drug injected into the eye. ROP causes abnormal blood vessel growth in the retina and can lead to blindness. The study collects real-world data on side effects and how …
Matched conditions: RETINOPATHY OF PREMATURITY
Sponsor: Bayer • Aim: Disease control
Last updated Jun 27, 2026 13:05 UTC
-
Can a lower dose of avastin save sight in preemies?
Disease control OngoingThis study tests whether lower doses of the drug bevacizumab (Avastin) can effectively treat a severe form of retinopathy of prematurity (ROP) in premature infants. The trial includes 77 babies with type 1 ROP in zone I, the most dangerous type. Each infant receives a single inje…
Matched conditions: RETINOPATHY OF PREMATURITY
Phase: PHASE2 • Sponsor: Jaeb Center for Health Research • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
AI eye exam could save premature Babies' sight
Diagnosis OngoingThis study tests an artificial intelligence system called i-ROP DL that analyzes images of the back of the eye. The goal is to see if it helps eye doctors more accurately diagnose retinopathy of prematurity (ROP), a condition that can cause blindness in premature infants. Researc…
Matched conditions: RETINOPATHY OF PREMATURITY
Phase: NA • Sponsor: Siloam Vision • Aim: Diagnosis
Last updated Jun 27, 2026 08:04 UTC
-
Premature Babies' vision tracked years after ROP treatment
Knowledge-focused OngoingThis study follows about 100 premature babies who were treated for retinopathy of prematurity (ROP) in an earlier study. Researchers will check their eyesight and overall development over time to see how they are doing. No new treatment is given in this study.
Matched conditions: RETINOPATHY OF PREMATURITY
Sponsor: Regeneron Pharmaceuticals • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:01 UTC